Drug Profile
DAA 1106
Latest Information Update: 14 Nov 2006
Price :
$50
*
At a glance
- Originator Nihon Nohyaku; Taisho Pharmaceutical
- Class Anxiolytics
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 14 Sep 1999 New profile
- 14 Sep 1999 Preclinical development for Anxiety disorders in Japan (Unknown route)